Sabra Health Care REIT Inc. announced that its subsidiary, Sabra Health Care Limited Partnership, will redeem its entire $500 million principal amount of outstanding 5.125% Senior Notes due 2026 on July 31, 2025. The redemption will be executed at a price equal to 100% of the principal amount, along with any accrued and unpaid interest up to the redemption date, plus a Make-Whole Amount as defined in the notes. Following this redemption, the notes will no longer accrue interest or remain outstanding. The Limited Partnership plans to finance the redemption through a $500 million term loan.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。